- Presentations
- 7
- Markets
- 1
Nexium is a brand of Esomeprazole marketed by AstraZeneca Pharmaceuticals, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Esomeprazole
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 20 mg delayed-release capsule, 40 mg delayed-release capsule, 10 mg delayed-release granules, 2.5 mg delayed-release granules, 20 mg delayed-release granules, 40 mg delayed-release granules, 5 mg delayed-release granules
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Nexium 20 mg delayed-release capsuleOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Nexium 40 mg delayed-release capsuleOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Nexium 10 mg delayed-release granulesOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Nexium 2.5 mg delayed-release granulesOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Nexium 20 mg delayed-release granulesOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Nexium 40 mg delayed-release granulesOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Nexium 5 mg delayed-release granulesOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Nexium
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.